Clinical Trial Update: Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing whether TV003 vaccination or prior Zika exposure provides protection against ZIKV-SJRP challenge compared with dengue exposure …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Zika Virus Disease

Drugs mentioned

• TV003

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Zika Virus | Phase 1 | Status: COMPLETED